Zydus Lifesciences Limited has announced a significant buyback of its equity shares, aiming to repurchase up to 87,30,158 equity shares. The buyback will be conducted at a price of ₹1,260 per share, aggregating up to approximately ₹1,100 crore. The offer period commences on June 4, 2026, and closes on June 10, 2026. This initiative is part of the company’s capital allocation strategy to enhance shareholder value.
Zydus Lifesciences Announces Major Share Buyback
Zydus Lifesciences Limited has formally initiated a substantial buyback program, proposing to acquire up to 87,30,158 fully paid-up equity shares. Each share will be repurchased at a price of ₹1,260, representing a total aggregate value not exceeding ₹1,100 crore. This strategic move reflects the company’s commitment to returning surplus cash to its shareholders and enhancing overall shareholder value. The buyback is being executed through the ‘tender offer’ route, adhering to the SEBI (Buy-Back of Securities) Regulations, 2018.
Key Dates and Entitlements
The buyback process is scheduled to commence on Thursday, June 4, 2026, with the buyback opening date. The offer will officially close on Wednesday, June 10, 2026. A critical date for determining shareholder entitlement is the Record Date, fixed as May 29, 2026. Shareholders are categorized into ‘Small Shareholders’ and ‘General Category’ for entitlement purposes. Small Shareholders will have an indicative entitlement ratio of 5 equity shares for every 49 held, while the General Category shareholders will have an indicative ratio of 7 equity shares for every 937 held.
Financial and Strategic Rationale
The company has confirmed that the buyback funds will be sourced from its free reserves and/or other permissible sources, explicitly stating that borrowed funds will not be utilized. The buyback is expected to improve key financial metrics such as return on net worth and return on equity. Management believes this initiative will not impair the company’s ability to pursue growth opportunities or meet its cash requirements. The buyback price of ₹1,260 per share represents a premium over recent market prices, reflecting the company’s valuation assessment.
Promoter Participation
Members of the Promoter and Promoter Group have expressed their intention to participate in the buyback, tendering a significant number of their equity shares. This participation is expected to potentially increase their aggregate shareholding slightly post-buyback, without altering the company’s control structure. The shareholding pattern analysis indicates that the Promoter and Promoter Group hold approximately 74.99% of the company’s equity share capital prior to the buyback.
Statutory Compliance and Declarations
The company has received necessary approvals and has made all required disclosures as per the Buyback Regulations. The Board of Directors has made declarations confirming the company’s financial soundness and its ability to meet its obligations. The statutory auditors, Deloitte Haskins & Sells LLP, have issued a report stating that the permissible capital payment has been properly determined and that the company is not expected to become insolvent within a year of the board meeting approving the buyback. All documents related to the buyback are available for inspection at the company’s registered office.
Source: BSE
